Replacement of the human topoisomerase linker domain with the plasmodial counterpart renders the enzyme camptothecin resistant.
A human/plasmodial hybrid enzyme, generated by swapping the human topoisomerase IB linker domain with the corresponding domain of the Plasmodium falciparum enzyme, has been produced and characterized. The hybrid enzyme displays a relaxation activity comparable to the human enzyme, but it is characte...
Main Authors: | Barbara Arnò, Ilda D'Annessa, Cinzia Tesauro, Laura Zuccaro, Alessio Ottaviani, Birgitta Knudsen, Paola Fiorani, Alessandro Desideri |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3699648?pdf=render |
Similar Items
-
Binding of an Indenoisoquinoline to the topoisomerase-DNA complex induces reduction of linker mobility and strengthening of protein-DNA interaction.
by: Giordano Mancini, et al.
Published: (2012-01-01) -
Structural and dynamical effects induced by the anticancer drug topotecan on the human topoisomerase I - DNA complex.
by: Giordano Mancini, et al.
Published: (2010-01-01) -
Natural Compounds as Therapeutic Agents: The Case of Human Topoisomerase IB
by: Alessio Ottaviani, et al.
Published: (2021-04-01) -
Different Camptothecin Sensitivities in Subpopulations of Colon Cancer Cells Correlate with Expression of Different Phospho-Isoforms of Topoisomerase I with Different Activities
by: Cinzia Tesauro, et al.
Published: (2020-05-01) -
Decreased camptothecin sensitivity of the stem-cell-like fraction of Caco2 cells correlates with an altered phosphorylation pattern of topoisomerase I.
by: Amit Roy, et al.
Published: (2014-01-01)